Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Endocrine 2Other 1

Conditions

Adrenal Gland Neoplasms 5Adrenal incidentaloma 3Pheochromocytoma 2Hypertension 2Cushing Syndrome 2Urinary Bladder Neoplasms 1Osteoporosis 1Obesity 1Hypokalemia 1Hypercholesterolemia 1Hyperaldosteronism 1Diabetes Mellitus 1Carcinoma, Renal Cell 1Adrenocortical Carcinoma 1Adrenocortical Adenoma 1

Interventions

relacorilant 6Mifepristone 4Osilodrostat 3Corlux 3Metyrapone 2Adrenalectomy 2pembrolizumab 1Perceived Stress Scale 1Observation 1Dabigatran 1Continuous Glucose Monitoring 1Abiraterone Acetate 1ASP3662 14-amino-4'-hydroxylaminodiphenylsulfone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Cushing Syndrome × Adrenalectomy × Clear all
NCT04127552 2025-03-28

ITACA

University of Roma La Sapienza

Recruiting
68 enrolled
Endocrine

Adrenal incidentaloma, Adrenal Gland Neoplasms, Cushing Syndrome

NCT02001051 2018-06-14

Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
4 enrolled 10 charts
EndocrineOther

Adrenal incidentaloma, Adrenal Gland Neoplasms, Cushing Syndrome, Diabetes Mellitus, Hypercholesterolemia, Hypertension, Obesity, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡